RhumbLine Advisers’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,127
| Closed | -$58.6K | – | 4280 |
|
|
2025
Q1 | $58.6K | Buy |
27,127
+1,571
| +6% | +$3.39K | ﹤0.01% | 3536 |
|
|
2024
Q4 | $108K | Buy |
25,556
+5,008
| +24% | +$21.2K | ﹤0.01% | 3458 |
|
|
2024
Q3 | $235K | Buy |
20,548
+10,009
| +95% | +$114K | ﹤0.01% | 3155 |
|
|
2024
Q2 | $113K | Buy |
+10,539
| New | +$113K | ﹤0.01% | 3487 |
|